Skip to main content
Log in

QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Over activation of poly (ADP-ribose) polymerase has been involved in the pathogenesis of several diseases including stroke, myocardial infarction, diabetes, shock, neurodegenerative disorder, allergy, and several other inflammatory processes. Owing to the dual response of PARP-1 to DNA damage and its involvement in cell death, pharmacological modulation of PARP-1 activity may constitute a useful tool to increase the activity of DNA-binding antitumor drugs. Quantitative structure activity relationship (QSAR) study vis-à-vis physico-chemical parameters and forward feed neural network analysis for a series of phthalazinone derivatives as potent inhibitors of poly (ADP-ribose) polymerase was performed. The result of QSAR studies obtained allows us to recognize such physico-chemical parameters of phthalazinone derivatives which can be strictly related to the PARP-1 inhibitory activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Costantino G (2001) Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure–activity relationship analysis. J Med Chem 44:3786–3794

    Article  PubMed  CAS  Google Scholar 

  • D’Amours D, Desnoyers S, D’Silva I, Poirier GG (1999) Poly(ADPribosyl)ation reactions in the regulation of nuclear functions. Biochem J 342:249–268

    Article  PubMed  Google Scholar 

  • Griffin RJ, Pemberton LC, Rhodes D, Bleasdale C, Bowman K, Calvert AH, Curtin NJ, Durkacz BW, Newell DR, Porteous JK, Golding BT (1995) Anticancer Drug Des 10:507–514

    PubMed  CAS  Google Scholar 

  • Lautier DJ, Lagueaux J, Thibodeau LM, Poirier GG (1993) Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 122(2):171–193

    Article  PubMed  CAS  Google Scholar 

  • Lindahl T, Satoh MS, Poirier GG, Klungland A (1995) Posttranslational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem Sci 20(10):405–411

    Article  PubMed  CAS  Google Scholar 

  • Loh VM, Cockcroft X, Dillon KJ, Dixon L, Drzewiecki J, Eversley PJ, Gomez S, Hoare J, Kerrigan F, Matthews ITW, Menear KA, Martin NMB, Newton RF, Paul J, Smith GCM, Vilec J, Whittlec AJ (2005) Phthalazinones. Part 1: the design and synthesis of a novel series of potent inhibitors of poly (ADP-ribose) polymerase. Bioorg Med Chem Lett 15(2):235–2238

    Google Scholar 

  • Martin DS, Bertino JR, Koutcher JA (2000) ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach. Cancer Res 60(24):6776–6783

    PubMed  CAS  Google Scholar 

  • Murthy VS, Kulkarni VM (2002) 3D-QSAR CoMFA and CoMSIA on protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem 10:2267–2282

    Article  PubMed  CAS  Google Scholar 

  • Ogata N, Ueda K, Kawaichi M, Hayaishi O (1981) Poly(ADP-ribose) synthetase, a main acceptor of poly(ADP-ribose) in isolated nuclei. J Biol Chem 256:4135–4137

    PubMed  CAS  Google Scholar 

  • Puntambekar D, Giridhar R, Yadav MR (2006) 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach. Bioorg Med Chem Lett 16:1821–1827

    Article  PubMed  CAS  Google Scholar 

  • Purnell MR, Whish WJD (1980) Novel inhibitors of poly(ADP-ribose)synthetase. Biochem J 185:775

    PubMed  CAS  Google Scholar 

  • Skalitzky DJ, Marakovits JT, Maegley KA (2003) Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors. J Med Chem 46(2):210–213

    Article  PubMed  CAS  Google Scholar 

  • Southan GJ, Szabo C (2003) Poly(ADP-ribose) polymerase inhibitors. Curr Med Chem 10(4):321–340

    PubMed  CAS  Google Scholar 

  • Srivastava AK (2008) Quantitative structure activity relationship studies on a novel series of phthalazinone as potent poly(ADP-ribose) polymerase inhibitors. Proc Natl Acad Sci India Sect A 78A:37–44

    Google Scholar 

  • Suto MJ, Turner WR, Arundel-Suto CM, Werbel LM, Sebolt-Leopold JS (1991) Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly(ADP-ribose) polymerase. Anticancer Drug Des 6:107–117

    PubMed  CAS  Google Scholar 

  • Tentori L, Portarena I, Graziani G (2002) Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45(2):73–85

    Article  PubMed  CAS  Google Scholar 

  • Zupan J, Gasteiger J (1993) Neural networks for chemists: an introduction. VCH, Weinheim

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ganesh R. Kokil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rewatkar, P.V., Kokil, G.R. & Raut, M.K. QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase. Med Chem Res 20, 877–886 (2011). https://doi.org/10.1007/s00044-010-9414-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-010-9414-2

Keywords

Navigation